A recurring pattern in this section deserves examination. Members frequently report losing most of their post-cycle gains and attribute the outcome to PCT protocol choice. Reviewing the accompanying logs, a different interpretation seems at least as plausible.
The endocrine system adapts to sustained conditions. When exogenous androgen exposure spans four to five months, the axis receives a prolonged signal of redundancy, and recovery timelines reflect that duration far more than the weeks surrounding discontinuation. PCT operates within a narrow physiological window. It initiates gonadotropin signaling, but tissue retention appears predominantly governed by cycle length, compound selection, and the degree of prior suppression.
This reframing has practical consequences. If recovery variance tracks suppression burden rather than PCT selection, then the extensive attention devoted to protocol comparison may be addressing a downstream variable while treating the upstream one as fixed. Distinguishing between these two explanations would require measurement, not opinion.
Among members who have run multiple cycles of different lengths, does the pattern in your own history support the hypothesis that suppression burden predicted retention more reliably than PCT composition? Documented examples would make this thread genuinely useful.
Created
5 hours ago
-
Last Reply
5 hours ago
- 0
replies
- 18
views
- 0
users
- 0
likes
